Forum for Science, Industry and Business

Sponsored by:     3M 
Search our Site:

 

Estrogens as antioxidants - reducing heart disease in younger postmenopausal women

07.07.2003


HRT could be used to protect younger postmenopausal women from heart disease. An article published in the journal Lipids in Health and Disease shows that estrogens commonly used in HRT reduce the build up of harmful oxidised lipoproteins, which can lead to heart disease, by acting as antioxidants.



It is well known that high-density lipoproteins (HDL) protect against heart disease while low-density lipoproteins (LDL) promote it. However, recent research has shown that the relationship is not that simple. The effectiveness of both types of lipoprotein change when they are oxidised by free radicals – highly reactive by-products of metabolism. If LDL becomes oxidised its ability to cause heart disease increases. If HDL becomes oxidised its ability to protect against heart disease is lessened.

Researchers from St. Michael’s Hospital, part of the University of Toronto, have shown that estrogens can act as antioxidants, which neutralise free radicals, and hence protect HDL from oxidation. In addition, high levels of HDL are able to protect LDL from oxidation, and this ability is strongly enhanced when estrogens are present.


Dr Bhagu Bhavnani’s team, who carried out the research, write, “The inhibition of HDL oxidation and the enhancement provided by estrogens toward the inhibition of LDL oxidation may be another way in which estrogens reduce the risk of coronary heart disease in healthy young postmenopausal women.”

Although recent randomised control trials have shown that HRT in older women may not reduce the incidence of coronary heart disease, Dr. Bhavnani believes that this is not the whole story. Although his team carried out experiments in test tubes rather than in human subjects they saw that estrogen had beneficial effects at concentrations lower than those found in women on HRT. He urges that, “randomised control trials using lower doses of HRT, different estrogens and progestins, and in younger postmenopausal women, from 50 to 60 years, are urgently needed to resolve the confusion created by recent studies”.

The research team used blood taken from men and postmenopausal women to carry out experiments in vitro. They measured the resistance of HDL to oxidation in the presence or absence of increasing concentrations of eleven different estrogens. All of these estrogens are components of a combined estrogen supplement that is commonly used for HRT by postmenopausal women. They then assessed whether the presence of HDL increased the resistance of LDL to oxidation, and if this resistance was further enhanced by the addition of estrogen.

They found that all the estrogens tested were able to protect HDL from oxidation and to enhance HDL’s ability to protect LDL from oxidation. They also found that different estrogens had different potencies as antioxidants, with an estrogen called Equilenin being the most effective.

According to recent data from the British Heart Foundation, women are five times less likely to suffer from coronary heart disease than men. This reduced risk can only partly be explained by differences in behaviour, such as smoking or stress levels. As women’s risk of heart disease increases after menopause it has been suggested that ovarian hormones such as estrogen play a role in protecting younger women from the disease. The research from Bhavnani’s team supports this idea.

Gemma Bradley | BioMed Central
Further information:
http://www.biomedcentral.com
http://www.lipidworld.com/content/2/1/4

More articles from Health and Medicine:

nachricht How cancer metastasis happens: Researchers reveal a key mechanism
19.01.2018 | Weill Cornell Medicine

nachricht Researchers identify new way to unmask melanoma cells to the immune system
17.01.2018 | Duke University Medical Center

All articles from Health and Medicine >>>

The most recent press releases about innovation >>>

Die letzten 5 Focus-News des innovations-reports im Überblick:

Im Focus: Artificial agent designs quantum experiments

On the way to an intelligent laboratory, physicists from Innsbruck and Vienna present an artificial agent that autonomously designs quantum experiments. In initial experiments, the system has independently (re)discovered experimental techniques that are nowadays standard in modern quantum optical laboratories. This shows how machines could play a more creative role in research in the future.

We carry smartphones in our pockets, the streets are dotted with semi-autonomous cars, but in the research laboratory experiments are still being designed by...

Im Focus: Scientists decipher key principle behind reaction of metalloenzymes

So-called pre-distorted states accelerate photochemical reactions too

What enables electrons to be transferred swiftly, for example during photosynthesis? An interdisciplinary team of researchers has worked out the details of how...

Im Focus: The first precise measurement of a single molecule's effective charge

For the first time, scientists have precisely measured the effective electrical charge of a single molecule in solution. This fundamental insight of an SNSF Professor could also pave the way for future medical diagnostics.

Electrical charge is one of the key properties that allows molecules to interact. Life itself depends on this phenomenon: many biological processes involve...

Im Focus: Paradigm shift in Paris: Encouraging an holistic view of laser machining

At the JEC World Composite Show in Paris in March 2018, the Fraunhofer Institute for Laser Technology ILT will be focusing on the latest trends and innovations in laser machining of composites. Among other things, researchers at the booth shared with the Aachen Center for Integrative Lightweight Production (AZL) will demonstrate how lasers can be used for joining, structuring, cutting and drilling composite materials.

No other industry has attracted as much public attention to composite materials as the automotive industry, which along with the aerospace industry is a driver...

Im Focus: Room-temperature multiferroic thin films and their properties

Scientists at Tokyo Institute of Technology (Tokyo Tech) and Tohoku University have developed high-quality GFO epitaxial films and systematically investigated their ferroelectric and ferromagnetic properties. They also demonstrated the room-temperature magnetocapacitance effects of these GFO thin films.

Multiferroic materials show magnetically driven ferroelectricity. They are attracting increasing attention because of their fascinating properties such as...

All Focus news of the innovation-report >>>

Anzeige

Anzeige

Event News

10th International Symposium: “Advanced Battery Power – Kraftwerk Batterie” Münster, 10-11 April 2018

08.01.2018 | Event News

See, understand and experience the work of the future

11.12.2017 | Event News

Innovative strategies to tackle parasitic worms

08.12.2017 | Event News

 
Latest News

Let the good tubes roll

19.01.2018 | Materials Sciences

How cancer metastasis happens: Researchers reveal a key mechanism

19.01.2018 | Health and Medicine

Meteoritic stardust unlocks timing of supernova dust formation

19.01.2018 | Physics and Astronomy

VideoLinks
B2B-VideoLinks
More VideoLinks >>>